Aerska

About Aerska

Aerska is a biotechnology company developing targeted RNA medicines to treat brain diseases. It focuses on delivering RNA interference therapies across the blood-brain barrier to silence harmful genes, with the goal of preserving minds and memories for patients with CNS disorders. The company emphasizes brain-specific delivery, precision medicine, and biomarker-guided development to advance therapies for neurological diseases. Based in the neuroscience biotech ecosystem, it combines experts in RNAi, brain shuttles, and CNS drug development to expand treatment options for CNS conditions.